has_role organic heterocyclic compound rosiglitazone 0 357.11471 357.435 BRL-49653 CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione SNOMEDCT:326053005 ChemIDplus:122320-73-4 pubmed:31936729 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione chebi_ontology rosiglitazone SNOMEDCT:395869000 drugcentral:2405 ChEMBL:120027 rosiglitazona drugbank:DB00412 Beilstein:7082202 pubmed:33746608 pubmed:17259370 InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23) CHEBI:50122 beilstein:7082202 C18H19N3O3S cas:122320-73-4 pubmed:33650786 lincs.smallmolecule:LSM-1949 MESH:C089730 pubmed:30225267 NCIt:C62076 wikipedia.en:Rosiglitazone rosiglitazonum pubmed:32234642 YASAKCUCGLMORW-UHFFFAOYSA-N 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione patent:US5002953 patent:EP306228 insulin-sensitizing drug